![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Aptar Pharma names Jean-Marc Pardonge as prescription division new president
Aptar Pharma, a subsidiary of Aptargroup, has named Jean-Marc Pardonge as the new president for the company's prescription division. ...
Drug Research
FDA approves ThromboGenics vitreomacular adhesion therapy
The USFDA has approved ThromboGenics' Jetrea (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA). The approval was based...
Drug Research
University of Utah develops 90-day intravaginal ring for HIV drug delivery
University of Utah, in collaboration with CONRAD, has developed an intravaginal ring that delivers water soluble drug, tenofovir (TFV), for 90 days to...
Drug Research
USPTO grants NOA to Arrowhead’s new DPC siRNA delivery system
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Arrowhead Research's new formulation of dynamic polyconjugate (DPC)...
Drug Research
VentiRx, Celgene to develop cancer drug
 VentiRx Pharmaceuticals has formed a world-wide collaboration with Celgene Corporation to develop VTX-2337, a highly potent and selective TLR8 agonist for cancer treatment....
Drug Research
Atreca uses Immune Repertoire Capture technology to develop new vaccines
Atreca and Bill & Melinda Gates Foundation have collaborated to accelerate the discovery and development of new vaccines and therapeutics for human infectious...
Drug Research
US FDA approves Mylan Valsartan and Hydrochlorothiazide tablets
Mylan Pharmaceuticals, a subsidiary of Mylan, has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read